Interspecies extrapolation of physiological pharmacokinetic parameter distributions

Area of Science:

• Pharmacokinetics and toxicological modeling
• Interspecies extrapolation methods
• Physiologically-based pharmacokinetic (PBPK) modeling

Background:

• Accurate interspecies extrapolation is crucial for assessing human health risks from animal studies.
• Physiologically-based pharmacokinetic (PBPK) models are valuable tools for quantitative risk assessment.
• Developing reliable methods to scale PBPK model parameters across species is an ongoing challenge.

Purpose of the Study:

• To evaluate three methods (multiplicative, additive, allometric) for extrapolating PBPK model parameters from rats to humans.
• To assess the predictive performance of extrapolated models for benzene disposition in humans.
• To determine if rats serve as a suitable kinetic model for human benzene exposure.

Main Methods:

• Developed and applied multiplicative, additive, and allometric scaling methods to rat PBPK model parameters.
• Fitted independent PBPK models to rat and human benzene disposition data.
• Predicted bone marrow exposure and metabolite quantity in humans using extrapolated and human-fitted models.

Main Results:

• Extrapolated models showed poor prediction of human benzene disposition compared to human-fitted models.
• Prediction accuracy varied depending on the specific endpoint (e.g., bone marrow exposure vs. metabolite quantity).
• Multiplicative and allometric scaling could extrapolate parameter distributions, but rats poorly represent human benzene kinetics.

Conclusions:

• Rats are not a reliable kinetic model for human benzene disposition.
• Current extrapolation methods have limitations in accurately predicting human PBPK model behavior.
• Further refinement of interspecies scaling techniques is needed for robust toxicological risk assessment.